Regulatory, trial, research, coverage-policy, and direct organizational sources are weighted differently from secondary reporting.
Source transparency
Evidence first. Interpretation second.
CPI combines public regulatory, clinical, research, company, funding, coverage-policy, event, safety, and market evidence. Every signal keeps its source so users can inspect what the analysis rests on.
CPI looks for independent organizations, multiple source classes, recency, and repeat evidence before confidence rises.
Public-source gaps, reporting lags, and ambiguous entity matching remain visible limitations. Medicare coverage-policy activity is also kept distinct from FDA authorization, clinical effectiveness, and guaranteed payment.
Current source universe
… indexed signals in the current 12-month view
Loading source catalog…
